0001784334-19-000002.txt : 20190821 0001784334-19-000002.hdr.sgml : 20190821 20190821100611 ACCESSION NUMBER: 0001784334-19-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c ITEM INFORMATION: 4a5 FILED AS OF DATE: 20190821 DATE AS OF CHANGE: 20190821 EFFECTIVENESS DATE: 20190821 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cao Pharmaceuticals Inc.15 CENTRAL INDEX KEY: 0001784334 IRS NUMBER: 473979218 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-347058 FILM NUMBER: 191041404 BUSINESS ADDRESS: STREET 1: 17490 HIGHWAY 3, SUITE B200 CITY: WEBSTER STATE: TX ZIP: 77598 BUSINESS PHONE: 832-283-7705 MAIL ADDRESS: STREET 1: 17490 HIGHWAY 3, SUITE B200 CITY: WEBSTER STATE: TX ZIP: 77598 D 1 primary_doc.xml X0708 D LIVE 0001784334 Cao Pharmaceuticals Inc.15 17490 HIGHWAY 3, SUITE B200 WEBSTER TX TEXAS 77598 832-283-7705 TEXAS None None Corporation true 2015 Zhisong Cao 17490 Hwy 3, Suite B200 Webster TX TEXAS 77598 Executive Officer Director Promoter CEO, Director, and Chief Chemist Doug Coil 17490 Hwy 3, Suite B200 Webster TX TEXAS 77598 Executive Officer Clinical Director Yang Wang 17490 Hwy 3, Suite B200 Webster TX TEXAS 77598 Executive Officer Chief Pharmacologist Pharmaceuticals Decline to Disclose 06c 4a5 false true false true true CZ48 Drug Revenue Interests (see the Offering Memorandum) false 25000 16000000 0 16000000 false 0 0 true 0 true See the Issuer's Offering Memorandum. 0 true See the Issuer's Offering Memorandum. false Cao Pharmaceuticals Inc.15 Zhisong Cao Zhisong Cao CEO 2019-08-21